New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 3, 2014
11:15 EDTQUREuniQure announces analysis of six-year follow-up data for Glybera
uniQure announced the full analysis of the six-year follow-up data for patients treated once with Glybera, uniQure's gene therapy product for the treatment of lipoprotein lipase deficiency. Glybera is approved in the EU as a treatment for LPLD, a potentially life-threatening, orphan metabolic disease that results in patients' inability to process fat in the blood after a meal. LPLD patients eligible for Glybera treatment suffer from reoccurring and often severe pancreatitis events leading to recurrent admissions to hospitals and intensive care units.
News For QURE From The Last 14 Days
Check below for free stories on QURE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
05:50 EDTQUREuniQure focused on start of hemophilia B clinical trial in 2H14
Subscribe for More Information
05:49 EDTQUREuniQure signed distribution agreement with Medison Pharma
Subscribe for More Information
05:48 EDTQUREuniQure reports Q2 EPS (EUR 0.51) vs. (EUR 80) last year
Reports Q2 revenue EUR 1.04M vs. EUR 758,000 last year.
August 31, 2014
13:41 EDTQURECitigroup to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use